Runnymede Capital Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,370
Closed -$167K 154
2025
Q1
$167K Sell
2,370
-120
-5% -$8.47K 0.16% 74
2024
Q4
$164K Buy
+2,490
New +$164K 0.14% 79